article thumbnail

Is Livongo-Teladoc merger a ‘leap forward’ for digital health?

pharmaphorum

While both companies operate in virtual care and chronic condition management, their approaches are very different. Its second-quarter revenue leaped 125% to almost $92 million.

article thumbnail

Express Scripts on the Road to Damascus?

Ramblings of a pharmacist

It’s a very useful metric for chronic diabetes management, because since red blood cells stick around in the blood for ~3 months, it can give you a sense of how well controlled a person’s diabetes is over the past three months, even if their current blood sugar is perfectly normal. They do… to a point.